Healthcare Triangle Reports 627% Increase in Gross Profit and 166% Increase in Revenue for Q1 2026
Rhea-AI Summary
Healthcare Triangle (Nasdaq:HCTI) reported strong Q1 2026 results, driven by its January acquisition of Teyame 360 and Datono.
Revenue rose 166% year-over-year to $9.9M, while gross profit increased 627% to $2.4M and gross margin expanded from 9% to 24%.
The new Customer Engagement Services segment, created from the acquired businesses, delivered $6.9M revenue (about 70% of total), $2.0M gross profit and roughly 29% segment margin, offsetting modest declines in legacy Software Services and Managed Services. Management expects further gross margin improvement as integration and cross-selling progress.
AI-generated analysis. Not financial advice.
Positive
- Q1 2026 revenue up 166% year-over-year to $9.9M
- Gross profit up 627% year-over-year to $2.4M
- Consolidated gross margin improved 15 points from 9% to 24%
- Acquired businesses contributed $6.9M revenue, about 70% of Q1 2026 total
- Customer Engagement Services segment generated $2.0M gross profit at ~29% margin
Negative
- Legacy Software Services and Managed Services segments experienced modest revenue declines
News Market Reaction – HCTI
On the day this news was published, HCTI gained 4.11%, reflecting a moderate positive market reaction. Argus tracked a peak move of +10.3% during that session. Argus tracked a trough of -19.8% from its starting point during tracking. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $177K to the company's valuation, bringing the market cap to $4.49M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
HCTI slipped 0.9% while momentum-screened peers were mixed: BEAT rose 3.9% and DRIO fell 10.0%. Broader sector peers show both gains (VSEE, BFRG) and losses (MGRX, STRM), supporting a stock-specific rather than sector-wide move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Apr 23 | AI platform launch | Positive | -9.3% | Launch of ZoraNex AI self-care therapy app targeting $450B mental health market. |
| Apr 08 | Africa client wins | Positive | -3.3% | New healthcare clients across multiple African countries and LIMS partnership in Ethiopia. |
| Mar 25 | Agentic AI rollout | Positive | -4.8% | Deployment of Agentic AI in Teyame.AI platform targeting U.S. and LatAm markets. |
| Mar 11 | Share repurchase plan | Positive | -4.3% | Board approval of a $2,000,000 share repurchase program funded from available liquidity. |
| Feb 27 | Dubai expansion | Positive | -17.5% | QuantumNexis launch in Dubai to drive digital health and AI hospital solutions in GCC. |
Recent news — including AI launches, expansion, and a buyback authorization — was followed by negative 24-hour price reactions in every case, indicating a pattern of selling into announcements.
Over the last few months, HCTI has issued multiple growth-focused updates, from AI product launches and African and GCC expansion to new client wins and a $2M share repurchase plan. Despite generally positive strategic tone, each of the last five news events saw a negative 24-hour price move, including a -17.53% drop after the Dubai expansion and -9.27% after the ZoraNex AI self-care launch. Today’s strong Q1 2026 revenue and gross profit growth arrives against that backdrop of consistent post-news weakness.
Regulatory & Risk Context
An effective S-3/A shelf dated Nov 19, 2025 registers 1,458,118 common shares for resale tied to inducement and advisor warrants. The company has already received $2.85 million from prior warrant exercises and may receive additional cash if warrants are exercised at the $3.00 strike. The filing explicitly notes that adding freely tradable shares could pressure the stock price and dilute existing holders.
Market Pulse Summary
This announcement highlights a transformative Q1 2026, with revenue reaching $9.9M (up 166%) and gross profit $2.4M (up 627%). The Teyame and Datono acquisition contributed $6.9M of revenue and $2.0M gross profit at a 29% margin, lifting consolidated gross margin from 9% to 24%. Recent filings note expanded assets but also higher losses and active capital markets usage, so ongoing profitability, cash flows, and potential equity issuance remain key metrics to watch.
AI-generated analysis. Not financial advice.
Recent Acquisitions powers the Revenue Growth and Gross Profit
Q1 2026 Financial Highlights
Q1 2026 | Q1 2025 | Change | |
Total Revenue | +166 % | ||
Gross Profit | +627 % | ||
Gross Margin | 24 % | 9 % | + |
The Teyame and Datono Acquisition: A Transformative Quarter
The January 22, 2026 signing of HCTI's purchase agreement for the acquisitions of Teyame and Datono through the Company's wholly owned subsidiary, Teyame AI Holdings Inc., was the defining event of the first quarter and is the primary driver of the Company's strong financial performance. The acquired companies, which operate as an integrated AI-powered omnichannel customer experience, marketing, and financial and insurance distribution platform, contributed
This contribution established a new Customer Engagement Services segment that generated
Revenue impact: Total consolidated revenue grew by
Gross profit impact: Consolidated gross profit increased by approximately
Gross margin impact: The addition of Teyame and Datono's higher-margin revenue mix drove a 15-percentage-point expansion in consolidated gross margin, from
About Teyame and Datono
Teyame 360 S.L. is an AI-powered customer engagement company that combines artificial intelligence, telemarketing, and contact center operations to support customer acquisition, retention, and service for enterprises in financial services, insurance, and healthcare. Datono Mediacion S.L. complements Teyame as an insurance brokerage entity, facilitating the marketing and sales of insurance products. Together, the companies deliver a vertically integrated, full-cycle customer lifecycle solution — from AI-driven lead generation and customer acquisition through to conversion, policy distribution, and ongoing servicing.
David Ayanoglou, Chief Financial Officer of Healthcare Triangle, commented:
"The acquisition of Teyame and Datono has had an immediate and material positive impact on our financial results. In their very first quarter as part of Healthcare Triangle, these businesses contributed nearly
About Healthcare Triangle
Healthcare Triangle, Inc. based in
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995), and include, among others, statements regarding the consummation of the private placement, satisfaction of the customary closing conditions of the private placement and the use of the proceeds therefrom. Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties, and assumptions, including market and other conditions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors out lined in the company's annual report on form 10-K for the year ended December 31, 2025, on file with the Securities Exchange Commission (the "SEC") and in previous filings, subsequent filings and future periodic reports filed with the SEC. All the company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
Investors:
1-800-617-9550
ir@healthcaretriangle.com
Financial tables and full results are available in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.
View original content:https://www.prnewswire.com/news-releases/healthcare-triangle-reports-627-increase-in-gross-profit-and-166-increase-in-revenue-for-q1-2026-302771806.html
SOURCE Healthcare Triangle, Inc.